Keen Methods Medical (02595) Shares Rise 13.7% as Company Launches HK$472M Discounted Placement

According to company announcement, Keen Methods Medical (02595) launched a placement of 13.6 million new H-shares at HK$34.69 per share on July 15, representing a 9.71% discount to the previous close of HK$38.42. The placement raised HK$472 million in gross proceeds. As of 11:50 a.m., the stock traded at HK$43.68, up 13.7% for the day with turnover exceeding HK$220 million. The company will allocate approximately 75% of net proceeds toward development of core products including RAS inhibitors and innovative therapies.
Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments